Multidisciplinary Thyroid Tumor Program

Our nationally recognized team specializes in the evaluation and management of thyroid cancer, thyroid nodules, goiter, hyperthyroidism and hypothyroidism. We provide innovative, personalized care of the highest quality to patients across the thyroid disease spectrum, from the work up and management of thyroid nodules and benign thyroid conditions to the treatment thyroid cancer including advanced disease.

About the Program

CU Endocrinology’s Division Head, Dr. Whitney Goldner, and other faculty have complementary interest and expertise in basic, clinical, and translational thyroid disease research.

CU Endocrinology faculty provide clinical care at the University of �鶹��ý�� Hospital, the Denver Health Medical Center, and the Rocky Mountain VA Medical Center.
We utilize on-site ultrasound imaging and guided thyroid fine needle aspiration (FNA) biopsies, cytological and advanced molecular analysis., and a weekly multidisciplinary thyroid tumor clinic led by Connie Zuo, PAC to provide cutting edge care for patients with thyroid neoplasms and advanced thyroid cancer.
We collaborate with experienced colleagues in Endocrine Surgery, ENT, Nuclear Medicine, Radiology, Medical Oncology, Radiation Oncology and Pathology. This multidisciplinary team provides comprehensive state-of-the-art treatment options for patients with thyroid disease, including surgery, radioiodine therapy, dosimetry, radiation therapy, ablation of malignant lymph nodes, targeted chemotherapy and other cutting-edge medical treatments including clinical trials.

Our Division’s cutting edge scientific work and active clinical trials program further enhances innovation in clinical care.

Grave’s Disease: Immunovant trial for persons with difficult to control Grave’s disease. This is a novel treatment to reduce the antibodies that cause Grave’s disease and ultimately reduce hyperthyroidism and the need for medication.
Medullary thyroid cancer patient registry: This is a multi-institutional cancer registry sponsored by the International Thyroid Oncology Group (ITOG) that collect clinical information on enrolled patients. This registry allows us to combine valuable clinical and treatment information on persons being treated for MTC so that we can develop facilitate novel future treatments and improve overall outcomes
AI and thyroid nodules and cancer
Basic/Translational research studies
Environmental exposures and risk of thyroid cancer: We are studying the association between pesticide exposure and thyroid nodules and thyroid cancer in mouse models of thyroid cancer and epidemiologic association studies.

UCHealth Thrive Clinic

and , lead the UCH Thrive clinic – a clinical survivorship program for patients with thyroid cancer that is stable or in remission. The focus shifts from active cancer treatment to monitoring disease stability and emphasizing overall health and wellbeing.

The best care of patients with thyroid disease is accomplished by close partnerships among multiple specialties including primary care, endocrinology, endocrine surgery, radiology and pathology. Our center has the advantage of specialists in each of these specialties that closely collaborate to the advantage of the patient.
- Robert McIntyre, MD, Professor of Surgery Division Chief GI, Trauma and Endocrine Surgery

�鶹��ý��al Programs and Conferences

In addition to our comprehensive ACGME Endocrinology Fellowship, we offer a 1-year clinical and 2-year clinical/research Thyroid Cancer Fellowship:

Weekly multidisciplinary thyroid tumor clinic
Monthly multidisciplinary Radioactive Iodine Conference
Biennial Thyroid Nodule and Cancer Symposium and Patient �鶹��ý�� Day

Meet Our Team

Multidisciplinary Thyroid Tumor Program Leaders
Endocrinology	Radiology
	Toshi Clark - US
	- Interventional Radiology
	- Nuclear Medicine
	- Nuclear Medicine
	Nikhil Maduripan - US
	Lisa Walker, MD - Interventional Radiology
Bev McLaughlin, MA

ENT Head and Neck Surgery	ThRIVE Clinic



Endocrine Surgery	Pathology





Medical Oncology	Research

Madeleine Kane, MD, PhD


Radiation Oncology

Team Testimonials

I joined the Endocrine faculty in 1993 and like many of my colleagues, I have been recruited to many other institutions. This is such a wonderfully collaborative place, that I have never felt the need to go anywhere else. I am a clinician-scientist interested in clinical care for patients with thyroid nodules and cancer, as well as research to better understand how thyroid cancer progresses and novel therapeutic targets using thyroid cancer cell lines, novel mouse models of thyroid cancer and clinical trials in patients.

Bryan Haugen

MD, Professor, Endocrinology Division Head

I joined the Endocrine Division in 2015 and have no intention of ever leaving. I love the patient-centered, collaborative approach to thyroid care at CU. There is also a strong commitment to innovation in education. Our Endocrinology Fellowship provides outstanding, comprehensive training. Through our traditional fellowship and novel programs, like the Thyroid Cancer Fellowship, our goal is to train future leaders in thyroidology and endocrinology.

Sarah Mayson

MD, Associate Professor, Director of the Thyroid Nodule Clinical Program, Director of the Endocrinology Fellowship and Thyroid Cancer Fellowship

I'm an Endocrinologist with special interest in Thyroid Neoplasms. I joined CU in 2019 to be part of this great team known for its innovative research. I take care of patients with all stages of thyroid cancer, including advanced cases in a special clinic with a multidisciplinary approach. We are soon starting our Thyroid Cancer Transition Clinic to better support the change from pediatric to adult healthcare and improve the quality of care of patients with this chronic illness.

Amanda La Greca

MD, Assistant Professor, Endocrinology Faculty

�鶹��ý��

Tools & Resources

CU Campuses

CU Anschutz Medical Campus

Division of Endocrinology, Metabolism and Diabetes

School of Medicine